Department of Pathology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.
Department of Pathology, Tohoku University Hospital, Sendai 980-8575, Japan.
Hum Pathol. 2014 Apr;45(4):866-74. doi: 10.1016/j.humpath.2013.09.024. Epub 2014 Jan 8.
Neuroendocrine tumors (NETs) are highly vascularized, but the process of proliferation and maturation of vascular structures during tumor development and progression has remained unknown. We examined the structural alterations of intratumoral blood vessels in human gastroenteropancreatic NET. Microvessel density was evaluated using the endothelial cell markers vasohibin-1 (VASH-1), CD31, and endoglin in 135 cases. Double immunohistochemistry staining was performed to localize endothelium and pericytes on the same vessels using the pericyte marker nestin. The ratio of Ki-67/CD31 was significantly correlated with that of VASH-1/CD31 positivity (P<.001), indicating that the ratio of VASH-1/CD31 also reflects the status of neovascularization in NET. This ratio was higher in NET than in its nonneoplastic counterpart (P=.10) and tended to increase according to World Health Organization (WHO) grade, although the differences were not statistically significant (P=.32). The ratio of VASH-1/nestin-positive vessels, representing the maturation of neovessels, was also significantly higher in NET than in its nonneoplastic counterparts (P=.003). Among WHO grades, the ratio increased from grade 1 to grade 2 (P=.36) and decreased in neuroendocrine carcinoma (P=.34). Our results demonstrated that VASH-1/CD31 can be an ideal immunohistochemical marker for characterizing neovascularization in NET. The VASH-1/CD31 content increased with WHO grade, and the vessels covered by pericytes decreased in higher grades. These structural changes in the vessels are considered to play an important role in inducing tumor-cell proliferation.
神经内分泌肿瘤 (NET) 具有高度血管化的特点,但肿瘤发展和进展过程中血管结构的增殖和成熟过程仍不清楚。我们检查了人类胃肠胰神经内分泌肿瘤肿瘤内血管的结构改变。使用内皮细胞标志物血管生成素-1 (VASH-1)、CD31 和内皮层蛋白在 135 例病例中评估微血管密度。通过双重免疫组织化学染色,使用周细胞标志物巢蛋白在同一血管上定位内皮细胞和周细胞。Ki-67/CD31 比值与 VASH-1/CD31 阳性的比值显著相关(P<.001),表明 VASH-1/CD31 比值也反映了 NET 中新生血管的状态。该比值在 NET 中高于其非肿瘤对应物(P=.10),并且倾向于根据世界卫生组织(WHO)分级增加,尽管差异无统计学意义(P=.32)。代表新血管成熟的 VASH-1/巢蛋白阳性血管的比值在 NET 中也明显高于其非肿瘤对应物(P=.003)。在 WHO 分级中,该比值从 1 级增加到 2 级(P=.36),在神经内分泌癌中降低(P=.34)。我们的结果表明,VASH-1/CD31 可以作为一种理想的免疫组织化学标志物,用于描述 NET 中的新生血管。VASH-1/CD31 含量随着 WHO 分级的增加而增加,而被周细胞覆盖的血管在较高分级中减少。这些血管的结构变化被认为在诱导肿瘤细胞增殖中起着重要作用。